You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
| Title |
Intravenous Peramivir for Treatment of Influenza in Hospitalized Patients
|
|---|---|
| Published in |
Antiviral Therapy, May 2013
|
| DOI | 10.3851/imp2680 |
| Pubmed ID | |
| Authors |
Michael G Ison, Joseph Fraiz, Barry Heller, Luis Jauregui, Graham Mills, William O'Riordan, Brian O'Neil, E Geoffrey Playford, J Douglass Rolf, Eduardo Sada-Diaz, Jenna Elder, Phil Collis, Jaime E Hernandez, William P Sheridan |
| Abstract |
Influenza causes over 200,000 hospitalizations a year in the United States, but few antiviral treatment studies have focused on patients hospitalized with influenza. This open-label, randomized study was initiated during the 2009 H1N1 pandemic to help assess the antiviral activity, safety, and tolerability of 5-10 days treatment with two different dosing regimens of the intravenous neuraminidase inhibitor, peramivir, in hospitalized subjects with influenza. |
Mendeley readers
The data shown below were compiled from readership statistics for 62 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 62 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 9 | 15% |
| Student > Ph. D. Student | 8 | 13% |
| Researcher | 7 | 11% |
| Student > Master | 7 | 11% |
| Student > Bachelor | 6 | 10% |
| Other | 8 | 13% |
| Unknown | 17 | 27% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 18 | 29% |
| Pharmacology, Toxicology and Pharmaceutical Science | 6 | 10% |
| Immunology and Microbiology | 3 | 5% |
| Biochemistry, Genetics and Molecular Biology | 2 | 3% |
| Business, Management and Accounting | 2 | 3% |
| Other | 9 | 15% |
| Unknown | 22 | 35% |